Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04496830 · ClinicalTrials.gov registry record
SPINCOMS Biomarker Study
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 161
- Enrollment target
NCT04496830 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 161 participants.
The verdict
NCT04496830 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 161 participants
- Enrollment target
Study Summary
To determine if biomarker-based CSF testing is reliably detecting differences between patients with Multiple Sclerosis (MS), different MS-subtypes, and other central nervous system (CNS) diseases. This study will also look to identify biomarkers that could be used for the prediction, at the time of diagnosis, of the future disease clinical course and response to therapy. The SOMAscan assay will be used for CSF samples analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2023-11-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04496830
The ClinicalTrials.gov registry entry for NCT04496830 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04496830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04496830 about?
NCT04496830 is a clinical study titled "SPINCOMS Biomarker Study". To determine if biomarker-based CSF testing is reliably detecting differences between patients with Multiple Sclerosis (MS), different MS-subtypes, and other central nervous system (CNS) diseases. This study will also look to identify biomarkers that could be used for the prediction, at the time of ...
What is the current status of trial NCT04496830?
This trial is currently completed. The enrollment target is 161 participants. The study started on 2020-06-15. Estimated completion is 2023-11-24.
Who is sponsoring clinical trial NCT04496830?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.